DrugPatentWatch Database Preview

Drugs in Development Information for Rigosertib

« Back to Dashboard

Summary for Rigosertib

US Patents	11
International Patents	63
US Patent Applications	16
WIPO Patent Applications	16
Japanese Patent Applications	0
Clinical Trial Progress	Phase 3 (2010-11-01)
Vendors	19

US Patents for Rigosertib

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Rigosertib		Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders	Temple University - Of the Commonwealth System of Higher Education (Philadelphia, PA) Onconova Therapeutics, Inc. (Newtown, PA)
Rigosertib		Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones	Onconova Therapeutics, Inc. (Newtown, PA)
Rigosertib		Composition and methods for the treatment of proliferative diseases	Temple University - Of The Commonwealth System of Higher Education (Philadelphia, PA) Mount Sinai School of Medicine (New York, NY)
Rigosertib		Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis	Temple University--Of The Commonwealth System of Higher Education (Philadelphia, PA) Onconova Therapeutics, Inc. (Newtown, PA)
Rigosertib		Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones	Temple University--Of The Commonwealth System of Higher Education (Philadelphia, PA) Onconova Therapeutics, Inc. (Newtown, PA)
Rigosertib		Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkoxystyryl 4-substituted benzylsulfones	Onconova Therapeutics, Inc (Newtown, PA)

International Patents for Rigosertib

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Rigosertib	Austria	525067	2022-02-28
Rigosertib	Australia	2003213660	2022-02-28
Rigosertib	Canada	2477232	2022-02-28
Rigosertib	Eurasian Patent Organization	008736	2022-02-28
Rigosertib	Eurasian Patent Organization	200401124	2022-02-28
Rigosertib	European Patent Office	1487428	2022-02-28